Conclusion
Our findings reveal that empagliflozin inhibited chondrocytes ECM
degradation, inflammation and cellular senescence in vitro and prevented
cartilage degeneration in vivo by suppressing NF-κB signal pathway,
indicating a therapeutic potential in OA treatment.
Keywords: empagliflozin; chondrocyte; inflammation; senescence;
NF-κB.